viernes, 22 de noviembre de 2019

Three CEOs own up to biopharma’s bad reputation - STAT

Three CEOs own up to biopharma’s bad reputation - STAT

Daily Recap

STAT Plus: ‘The industry has earned it’: Three CEOs own up to biopharma’s bad reputation

By KATE SHERIDAN


EMILIE PICKERING FOR STAT
CEOs from Bluebird Bio, Sage Therapeutics, and Turning Point Therapeutics owned up to biopharma's bad reputation at a STAT Summit panel.

No hay comentarios: